Molecular Mechanisms of - and Exercise-Induced Cardiac Hypertrophy in Rats

Overview

Journal Evid Based Complement Alternat Med

Specialty Rehabilitation Medicine

Date 2021 May 31

PMID 34055008

Citations 4

Authors

Lubna Ibrahim Al Asoom

Affiliations

Soon will be listed here.

Abstract

Background: In our lab, we demonstrated cardiac hypertrophy induced by long-term administration of (Ns) with enhanced function. Therefore, we aim to investigate the molecular mechanisms of Ns-induced cardiac hypertrophy, compare it with that induced by exercise training, and explore any possible synergistic effect of these two interventions.

Method: Twenty adult Wistar male rats were divided into control (C), Ns-fed (N.s.), exercise-trained (Ex.), Ns-fed exercise-trained (N.s.Ex.) groups. 800 mg/kg of Ns was administered orally to N.s. rats. Ex. rats were trained on a treadmill with speed 18 m/min and grade 32° for two hours daily, and the N.s.Ex. group underwent both interventions. After 8 weeks, Immunohistochemical slides of the left ventricles were prepared using rat growth hormone (GH), insulin-like growth factor I (IGF-I), angiotensin-II receptors 1 (AT-I), endothelin-I (ET-1), Akt-1, and Erk-1. Cell diameter and number of nuclei were measured.

Results: Cardiomyocyte diameter, number of nuclei, GH, and Akt were significantly higher in N.s, Ex., and N.s.Ex groups compared with the controls. IGF-I, AT-1, and ET-1 were significantly higher in Ex. rats only compared with the controls. Erk-1 was lower in N.s., Ex., and N.s.Ex. compared with the controls.

Conclusion: We can conclude that Ns-induced cardiac hypertrophy is mediated by the GH-IGF I-PI3P-Akt pathway. Supplementation of Ns to exercise training protocol can block the upregulation of AT-I and ET-1. The combined N.s. exercise-induced cardiac hypertrophy might be a superior model of physiological cardiac hypertrophy and be used as a prophylactic therapy for athletes who are engaged in vigorous exercise activity.

Citing Articles

Tripartite motif‑containing 14 may aggravate cardiac hypertrophy via the AKT signalling pathway in neonatal rat cardiomyocytes and transgenic mice.

Hou H, Chen Y, Feng X, Xu G, Yan M Mol Med Rep. 2023; 28(3).

PMID: 37503784 PMC: 10433706. DOI: 10.3892/mmr.2023.13060.

The Effectiveness of and Ginger as Appetite Suppressants: An Experimental Study on Healthy Wistar Rats.

Al Asoom L, Alassaf M, AlSulaiman N, Boumarah D, Almubireek A, Alkaltham G Vasc Health Risk Manag. 2023; 19:1-11.

PMID: 36647392 PMC: 9840438. DOI: 10.2147/VHRM.S396295.

Is an Effective Bodyweight Lowering Agent and a Mitigator of Obesity Risk? A Literature Review.

Al Asoom L Vasc Health Risk Manag. 2022; 18:495-505.

PMID: 35855753 PMC: 9288173. DOI: 10.2147/VHRM.S373702.

L. Phytochemistry and Pharmacological Activities: A Review (2019-2021).

Dalli M, Bekkouch O, Azizi S, Azghar A, Gseyra N, Kim B Biomolecules. 2022; 12(1).

PMID: 35053168 PMC: 8773974. DOI: 10.3390/biom12010020.

References

Isgaard J, Kujacic V, Jennische E, Holmang A, Sun X, Hedner T . Growth hormone improves cardiac function in rats with experimental myocardial infarction. Eur J Clin Invest. 1997; 27(6):517-25. DOI: 10.1046/j.1365-2362.1997.1430692.x. View

Weeks K, Bernardo B, Ooi J, Patterson N, McMullen J . The IGF1-PI3K-Akt Signaling Pathway in Mediating Exercise-Induced Cardiac Hypertrophy and Protection. Adv Exp Med Biol. 2017; 1000:187-210. DOI: 10.1007/978-981-10-4304-8_12. View

Kim J, Wende A, Sena S, Theobald H, Soto J, Sloan C . Insulin-like growth factor I receptor signaling is required for exercise-induced cardiac hypertrophy. Mol Endocrinol. 2008; 22(11):2531-43. PMC: 2582541. DOI: 10.1210/me.2008-0265. View

Duerr R, Huang S, Miraliakbar H, Clark R, Chien K, ROSS Jr J . Insulin-like growth factor-1 enhances ventricular hypertrophy and function during the onset of experimental cardiac failure. J Clin Invest. 1995; 95(2):619-27. PMC: 295527. DOI: 10.1172/JCI117706. View

Cardoso F, Franca E, Serra F, Victorino A, de Almeida A, Fernandes J . Aerobic exercise reduces hippocampal ERK and p38 activation and improves memory of middle-aged rats. Hippocampus. 2017; 27(8):899-905. DOI: 10.1002/hipo.22740. View

Chen H, Sharma B, Akerberg B, Numi H, Kivela R, Saharinen P . The sinus venosus contributes to coronary vasculature through VEGFC-stimulated angiogenesis. Development. 2014; 141(23):4500-12. PMC: 4302936. DOI: 10.1242/dev.113639. View

Bruel A, Oxlund H, Nyengaard J . Growth hormone increases the total number of cardiac myocyte nuclei in young rats but not in old rats. Mech Ageing Dev. 2002; 123(10):1353-62. DOI: 10.1016/s0047-6374(02)00073-8. View

Al-Asoom L, Al-Shaikh B, Bamosa A, El-Bahai M . Effect of Nigella sativa supplementation to exercise training in a novel model of physiological cardiac hypertrophy. Cardiovasc Toxicol. 2014; 14(3):243-50. DOI: 10.1007/s12012-014-9248-0. View

Al Asoom L . Coronary angiogenic effect of long-term administration of Nigella sativa. BMC Complement Altern Med. 2017; 17(1):308. PMC: 5470270. DOI: 10.1186/s12906-017-1795-z. View

10.

Cittadini A, Stromer H, Katz S, Clark R, Moses A, Morgan J . Differential cardiac effects of growth hormone and insulin-like growth factor-1 in the rat. A combined in vivo and in vitro evaluation. Circulation. 1996; 93(4):800-9. DOI: 10.1161/01.cir.93.4.800. View

11.

Debosch B, Treskov I, Lupu T, Weinheimer C, Kovacs A, Courtois M . Akt1 is required for physiological cardiac growth. Circulation. 2006; 113(17):2097-104. DOI: 10.1161/CIRCULATIONAHA.105.595231. View

12.

Bernardo B, McMullen J . Molecular Aspects of Exercise-induced Cardiac Remodeling. Cardiol Clin. 2016; 34(4):515-530. DOI: 10.1016/j.ccl.2016.06.002. View

13.

Bruel A, Oxlund H, Nyengaard J . Growth hormone increases the total number of myocyte nuclei in the left ventricle of adult rats. Growth Horm IGF Res. 2002; 12(2):106-15. DOI: 10.1054/ghir.2002.0269. View

14.

Dong F, Esberg L, Roughead Z, Ren J, Saari J . Increased contractility of cardiomyocytes from copper-deficient rats is associated with upregulation of cardiac IGF-I receptor. Am J Physiol Heart Circ Physiol. 2005; 289(1):H78-84. DOI: 10.1152/ajpheart.01093.2004. View

15.

Donath M, Zapf J, Eppenberger-Eberhardt M, FROESCH E, Eppenberger H . Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc Natl Acad Sci U S A. 1994; 91(5):1686-90. PMC: 43228. DOI: 10.1073/pnas.91.5.1686. View

16.

Iemitsu M, Maeda S, Otsuki T, Goto K, Miyauchi T . Time course alterations of myocardial endothelin-1 production during the formation of exercise training-induced cardiac hypertrophy. Exp Biol Med (Maywood). 2006; 231(6):871-5. View

17.

Tanaka N, Ryoke T, Hongo M, Mao L, Rockman H, Clark R . Effects of growth hormone and IGF-I on cardiac hypertrophy and gene expression in mice. Am J Physiol. 1998; 275(2):H393-9. DOI: 10.1152/ajpheart.1998.275.2.H393. View

18.

Asoom L, Al-Hariri M . Cardiac Inotropic Effect of Long-Term Administration of Oral Thymoquinone. Evid Based Complement Alternat Med. 2019; 2019:8575136. PMC: 6614965. DOI: 10.1155/2019/8575136. View

19.

Ito H, Hiroe M, Hirata Y, Tsujino M, Adachi S, Shichiri M . Insulin-like growth factor-I induces hypertrophy with enhanced expression of muscle specific genes in cultured rat cardiomyocytes. Circulation. 1993; 87(5):1715-21. DOI: 10.1161/01.cir.87.5.1715. View

20.

Bernardo B, Weeks K, Pretorius L, McMullen J . Molecular distinction between physiological and pathological cardiac hypertrophy: experimental findings and therapeutic strategies. Pharmacol Ther. 2010; 128(1):191-227. DOI: 10.1016/j.pharmthera.2010.04.005. View